| 【Company Research】Zhejiang Jingsheng (300316 CH) – 2Q22 profit +1.4x YoY with strong cash flow; Raise earnings & TP on solid margin |
| 【Company Research】China Life (2628 HK) – New business volume growth turned positive in 2Q22 |
| 【Fixed Income Research】CARINC: Better than expected 1H22 results. Buy CARINC'24 as a carry play |
| 【Company Research】Nongfu Spring (9633 HK) – 1H22 beat on GPM; tea beverage should continue to drive growth over 2H |
| 【Company Research】SenseTime (20 HK) – A slower AI adoption pace amid macro uncertainties |
| 【Company Research】Proya Cosmetics (603605 CH) – 2Q in line with full year guidance maintained |
| 【Company Research】Mengniu (2319 HK) – 1H22 soft as expected; management remained upbeat on a strong sequential recovery for 2H |
| 【Company Research】ZhongAn Online (6060 HK) – 1H22 UW margin further improved |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – Encouraging preliminary clinical results of mRNA COVID-19 vaccine candidate |
| 【Fixed Income Research】JIAYUA: The exchange, consent and RSA |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
